The Texas Tech University School of Law Digital Repository

Supreme Court’s FDA Decisions Highlights Little Understood Issue of Preemption

Show simple item record

dc.contributor.author Bard, Jennifer S.
dc.date.accessioned 2010-03-31T18:29:39Z
dc.date.available 2010-03-31T18:29:39Z
dc.date.issued 2008
dc.identifier.citation 11 (2) ASBH Exchange 6 en_US
dc.identifier.uri http://hdl.handle.net/10601/294
dc.description.abstract Professor Bard analyzes the Supreme Court’s decision in Riegel v. Medtronic, 552 U.S. 312 (2008), as a way to highlight how the Supreme Court approaches the issue of preemption.
dc.language.iso en_US en_US
dc.publisher American Society for Bioethics and Humanities (ASBH) Exchange
dc.subject Preemption
dc.subject Commerce clause
dc.subject Medical devices
dc.subject FDA
dc.subject MDA
dc.title Supreme Court’s FDA Decisions Highlights Little Understood Issue of Preemption en_US
dc.type Article en_US


Files in this item

Files Size Format View
bard sup.ct..pdf 1.066Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

Search ScHOLAR

Browse

My Account